P21-activated Kinase-1 Phosphorylates and Transactivates Estrogen Receptor-alpha and Promotes Hyperplasia in Mammary Epithelium

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2002 Oct 11

PMID 12374744

Citations 73

Authors

Rui-An Wang

Abhijit Mazumdar

Ratna K Vadlamudi

Rakesh Kumar

Affiliations

Soon will be listed here.

Abstract

Stimulation of p21-activated kinase-1 (Pak1) induces cytoskeleton reorganization and signaling pathways in mammary cancer cells. Here, we show that inhibition of Pak1 kinase activity by a dominant-negative fragment or by short interference RNA markedly reduced the estrogen receptor-alpha (ER) transactivation functions. To understand the role of Pak1 in mammary glands, we developed a murine model expressing constitutively active Thr423 glutamic acid Pak1 driven by the beta-lactoglobulin promoter. We show that mammary glands from these mice developed widespread hyperplasia associated with apocrine metaplasia and lobuloalveolar hyperdevelopment during lactation. Mammary tissues with active Pak1 also exhibited an increased activation of mitogen-activated protein kinase and stimulated transactivation functions of the ER and expression of endogenous ER target genes. Furthermore, Pak1 directly phosphorylated the activation function-2 domain of the ER at the N-terminal residue Ser305, and its mutation to Ala (S305A) abolished the Pak1-mediated phosphorylation and transactivation functions of the ER, while its mutation to glutamic acid (S305E) promoted transactivation activity of ER. These findings reveal a novel role for the Pak1-ER pathway in promoting hyperplasia in mammary epithelium.

Citing Articles

Targeting P21-Activated Kinase-1 for Metastatic Prostate Cancer.

Somanath P, Chernoff J, Cummings B, Prasad S, Homan H Cancers (Basel). 2023; 15(8).

PMID: 37190165 PMC: 10137274. DOI: 10.3390/cancers15082236.

Estrogen-Receptor-Positive Breast Cancer in Postmenopausal Women: The Role of Body Composition and Physical Exercise.

Dimauro I, Grazioli E, Antinozzi C, Duranti G, Arminio A, Mancini A Int J Environ Res Public Health. 2021; 18(18).

PMID: 34574758 PMC: 8467802. DOI: 10.3390/ijerph18189834.

Rho GTPases: Big Players in Breast Cancer Initiation, Metastasis and Therapeutic Responses.

Humphries B, Wang Z, Yang C Cells. 2020; 9(10).

PMID: 32992837 PMC: 7600866. DOI: 10.3390/cells9102167.

Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases.

Kumar R, Paul A, Amjesh R, George B, Pillai M Cancer Metastasis Rev. 2020; 39(3):583-601.

PMID: 32820388 DOI: 10.1007/s10555-020-09922-6.

Ancient Evolutionary Origin of Intrinsically Disordered Cancer Risk Regions.

Pajkos M, Zeke A, Dosztanyi Z Biomolecules. 2020; 10(8).

PMID: 32731489 PMC: 7465906. DOI: 10.3390/biom10081115.

References

Campbell R, Bhat-Nakshatri P, Patel N, Constantinidou D, Ali S, Nakshatri H . Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem. 2001; 276(13):9817-24. DOI: 10.1074/jbc.M010840200. View

Kirma N, Gill K, Mandava U, Tekmal R . Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice. Cancer Res. 2001; 61(5):1910-8. View

Wang C, Fu M, Angeletti R, Reutens A, Albanese C, Lisanti M . Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity. J Biol Chem. 2001; 276(21):18375-83. DOI: 10.1074/jbc.M100800200. View

Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T . Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001; 411(6836):494-8. DOI: 10.1038/35078107. View

Seagroves T, Lydon J, Hovey R, Vonderhaar B, Rosen J . C/EBPbeta (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol. 2000; 14(3):359-68. DOI: 10.1210/mend.14.3.0434. View

Moore F, Da Silva C, Wilde J, Smarason A, Watson S, Lopez Bernal A . Up-regulation of p21- and RhoA-activated protein kinases in human pregnant myometrium. Biochem Biophys Res Commun. 2000; 269(2):322-6. DOI: 10.1006/bbrc.2000.2290. View

Harvell D, Strecker T, Tochacek M, Xie B, Pennington K, McComb R . Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci U S A. 2000; 97(6):2779-84. PMC: 16006. DOI: 10.1073/pnas.050569097. View

Adam L, Vadlamudi R, Mandal M, Chernoff J, Kumar R . Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1. J Biol Chem. 2000; 275(16):12041-50. DOI: 10.1074/jbc.275.16.12041. View

Chen D, Riedl T, Washbrook E, Pace P, Coombes R, Egly J . Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell. 2000; 6(1):127-37. View

10.

Vadlamudi R, Adam L, Wang R, Mandal M, Nguyen D, Sahin A . Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem. 2000; 275(46):36238-44. DOI: 10.1074/jbc.M002138200. View

11.

Mazumdar A, Wang R, Mishra S, Adam L, Mandal M, Vadlamudi R . Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol. 2001; 3(1):30-7. DOI: 10.1038/35050532. View

12.

Mehta R, Bhat K, HAWTHORNE M, Kopelovich L, Mehta R, Christov K . Induction of atypical ductal hyperplasia in mouse mammary gland organ culture. J Natl Cancer Inst. 2001; 93(14):1103-6. DOI: 10.1093/jnci/93.14.1103. View

13.

Mandal M, Taludker A, Wang R, Vadlamudi R, Kung H, Kumar R . Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells. J Biol Chem. 2001; 276(31):29403-9. DOI: 10.1074/jbc.M103129200. View

14.

Yu J, DeRuiter S, Turner D . RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A. 2002; 99(9):6047-52. PMC: 122899. DOI: 10.1073/pnas.092143499. View

15.

Li F, Adam L, Vadlamudi R, Zhou H, Sen S, Chernoff J . p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep. 2002; 3(8):767-73. PMC: 1084211. DOI: 10.1093/embo-reports/kvf157. View

16.

Kumar R, Wang R, Mazumdar A, Talukder A, Mandal M, Yang Z . A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm. Nature. 2002; 418(6898):654-7. DOI: 10.1038/nature00889. View

17.

Kumar R, Vadlamudi R . Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol. 2002; 193(2):133-44. DOI: 10.1002/jcp.10167. View

18.

Russo J, Tay L, Russo I . Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 1982; 2(1):5-73. DOI: 10.1007/BF01805718. View

19.

Krust A, Green S, Argos P, Kumar V, Walter P, Bornert J . The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J. 1986; 5(5):891-7. PMC: 1166879. DOI: 10.1002/j.1460-2075.1986.tb04300.x. View

20.

Bergman M, Karelus K, Felicio L, NELSON J . Tissue differences in estrogen receptor dynamics: nuclear retention, rate of replenishment, and transient receptor loss vary in hypothalamus, pituitary, and uterus of C57BL/6J mice. Endocrinology. 1987; 121(6):2065-74. DOI: 10.1210/endo-121-6-2065. View